Bhardwaj, MKashyap, S.2023-08-092023-08-092023-03Bhardwaj M, Kashyap S.. GOLD Strategy Update 2023: Rationale and Clinical Implications in Indian Perspective. Indian Journal of Chest Diseases & Allied Sciences. 2023 Mar; 65(1): 22-260377-9343http://imsear.searo.who.int/handle/123456789/221859Chronic obstructive lung disease (COPD) is a major contributor to global disease burden with a huge socioeconomic impact. Global initiative for chronic obstructive lung disease (GOLD) strategy update 2023 is a step forward in the direction of evidence-based practice. Key topics like taxonomic classification, ABE grouping, single inhaler triple therapy, correct use of inhalers, etc. would have a positive impact on documentation and prescription practices in COPD management. The tobacco consumption habits are peculiar in India. There is a variation in prevalence estimates across diverse cultures. Non-smoking risk factors are important in Indian subcontinent especially in female and younger populations. We discuss the rationale of latest GOLD strategy update, its implications, and challenges in the management of COPD in Indian context.ABE groupingChronic obstructive lung diseaseGlobal initiative for chronic obstructive lung disease 2023Journal ArticleIndiaDepartment of Pulmonary Medicine, Shri Lal Bahadur Shastri Medical College and Hospital, Mandi, Himachal Pradesh, IndiaAtal Medical and Research University, Mandi, Himachal Pradesh, India